Metabolic Disease Models
Call Us Now:
Talk To Us:
BioVenic provides tailored modeling, high-throughput chemical screening and computational analysis services for fish and invertebrates to boost metabolic research and drug discovery. Simulating human metabolic disorders in aquatic organisms is a robust research method for exploring energy homeostasis molecular networks and screening therapeutic drugs. These models offer unique evolutionary insights into nutrient metabolism, lipid storage and endocrine signaling, effectively complementing traditional mammalian experiments and offering excellent translational research value.
Fig 1. Zebrafish as a model for metabolic disease.1,3
Applicable Scenarios: Studying pancreatic beta cell destruction, insulin resistance, glucose uptake kinetics, and the secondary complications of chronic hyperglycemia.
Technical Capabilities: We construct transgenic lines with tissue specific fluorescent reporters labeling pancreatic islet cells, utilizing active gene disruption or customized chemical induction to replicate diabetic states and study glucose regulation.
Deliverables: Real time fluorescent islet imaging sequences, quantitative free glucose level measurement sheets, insulin signaling transcription data, and digital pancreatic morphology dossiers.
Applicable Scenarios: Investigating the cellular mechanisms of fat accumulation, adipose tissue expansion, adipocyte hypertrophy, and the systemic effects of lipid storage.
Technical Capabilities: We leverage specialized feeding regimes and vital lipophilic fluorescent dyes to monitor active adipocyte development and evaluate the lipid reducing effects of novel anti-obesity candidates.
Deliverables: Quantitative lipid droplet volume assays, whole body adipose tissue distribution maps, in vivo fat accumulation velocity profiles, and compound efficacy reports.
Applicable Scenarios: Modeling hepatic steatosis, evaluating liver structure and function changes, tracking lipid infiltration, and assessing therapeutic interventions.
Technical Capabilities: We establish precise fatty liver models utilizing highly specialized high fat diets, molecular target knockouts, or chemical exposure to study progression from simple steatosis to chronic hepatic inflammation.
Deliverables: High resolution histopathology digital images, quantitative liver lipid volume metrics, hepatic inflammation transcription profiles, and liver function biochemical reports.
Applicable Scenarios: Replicating multifactorial human syndromes to study the interactions of glucose metabolism, lipid accumulation, and blood pressure variations.
Technical Capabilities: We integrate genetic modifications with customized nutritional challenges to generate models exhibiting concurrent hyperglycemia, obesity, vascular lipid deposition, and metabolic stress.
Deliverables: Interactive metabolic parameter correlation sheets, multi organ fluorescent imaging portfolios, lipid profile assays, and complete physiological validation dossiers.
Our systematic model development and characterization pipeline is optimized to deliver publication ready datasets and high fidelity translational insights.
Elucidating the underlying molecular and cellular cascades that drive insulin resistance, pancreatic dysfunction, and lipid dysregulation.
Performing rapid screenings of small molecule libraries to identify candidate therapeutics for obesity, diabetes, and hepatic steatosis.
Using sentinel aquatic models to evaluate how plasticizers, pesticides, and other endocrine disrupting chemicals impair metabolic health.
Evaluating how metabolic disorders compromise cardiac performance, delay wound healing, and accelerate tissue scarring.
Recent studies validate adult zebrafish (Danio rerio) as an exceptional translational model for investigating how diabetes compromises neurological function. Research demonstrates that chronic hyperglycemia alters brain homeostasis, promoting blood brain barrier integrity defects, severe neuroinflammation, and elevated oxidative stress. Hyperglycemic cohorts exhibit reduced superoxide dismutase activity, reactive gliosis marked by upregulated gfap expression, and significantly impaired regenerative neurogenesis. Behaviorally, these physiological alterations translate into anxiety like behaviors and cognitive deficits linked to impaired purinergic signaling, directly replicating pathologies observed in diabetic rodents.
BioVenic leverages these peer reviewed paradigms to construct stable metabolic models, providing robust, high resolution digital validation datasets for translational drug discovery.
Fig 2. The impact of metabolic diseases on peripheral and central mechanisms of brain homeostasis.2,3
BioVenic is committed to driving progress in aquatic biological and metabolic research through high-quality aquatic animal metabolic disease models. We understand that validated metabolic models are vital for studying disease mechanisms, analyzing nutritional regulation, and screening effective intervention strategies for aquatic species. Our professional technical team provides standardized and tailor-made model construction services to fit your research goals. To discuss your specific project requirements, explore our technical capabilities, or receive a detailed quote for your study, please contact us. Our experts stand ready to support your research and deliver valuable scientific outcomes.
References
Our products and services are for research use only and cannot be used for any clinical purposes.